Pergi ke luar talian dengan aplikasi Player FM !
4/6/2022 - New COVID-19 Treatment Guidelines
Manage episode 326345755 series 2065653
Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendations
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine
David Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus
Hosted on Acast. See acast.com/privacy for more information.
211 episod
Manage episode 326345755 series 2065653
Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients hospitalized with COVID-19. Topics: *New data on efficacy of available therapies *Immunomodulators for critical care patients *Updated NIH recommendations
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-6-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Sherrilyn and Ken Fisher Professor of Medicine at Johns Hopkins University School of Medicine
David Klimpl, MD, Assistant Professor at University of Colorado Denver – Anschutz Medical Campus
Hosted on Acast. See acast.com/privacy for more information.
211 episod
كل الحلقات
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.